1. Where does signet-ring cell carcinoma come from and where does it go?

   • Tomio Arai

   Editorial 08 April 2019 Pages: 651 - 652

2. The therapeutic potential of metformin in gastric cancer

   • Sarah Courtois
   • Philippe Lehours
   • Emilie Bessède

   Review Article 21 March 2019 Pages: 653 - 662

   

3. Mediterranean diet adherence and risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study

   • Maya Schulpen
   • Petra H. Peeters
   • Piet A. van den Brandt

   Original Article Open access 15 February 2019 Pages: 663 - 674

   

4. Unequal burden of mortality from gastric cancer in Brazil and its regions, 2000–2015

   • Lucia Libanez Bessa Campelo Braga
   • Alberto Novaes Ramos Jr.
   • Jorg Heukelbach

   Original Article 02 January 2019 Pages: 675 - 683

   

5. Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer

   • Tsutomu Namikawa
   • Nobuko Ishida
   • Kazuhiro Hanazaki

   Original Article 11 November 2018 Pages: 684 - 691

   

6. Prognostic and clinicopathological significance of long noncoding RNA CTD-2510F5.4 in gastric cancer

   • Zhe Wang
   • Baoli Qin

   Original Article Open access 17 December 2018 Pages: 692 - 704

   

7. MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression

   • Wei Guo
   • Xiaoliang Liang
   • Zhiming Dong

   Original Article 17 January 2019 Pages: 705 - 722

   

8. Gastric lymphatic flows may change before and after endoscopic submucosal dissection: in vivo porcine survival models

   • Kyoko Nohara
   • Osamu Goto
   • Yuko Kitagawa

   Original Article 02 January 2019 Pages: 723 - 730

   

9. Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis

   • Rui Zheng
   • Jiayuan Liang
   • Zhengdong Zhang

   Original Article 02 January 2019 Pages: 731 - 741

   

10. Identification of early genetic changes in well-differentiated intramucosal gastric carcinoma by target deep sequencing

    • Takashi Yoshida
    • Tatsuya Yamaguchi
    • Nobuyuki Enomoto

    Original Article 11 February 2019 Pages: 742 - 750

    

11. Effect of double-layer structure in intramucosal gastric signet-ring cell carcinoma on lymph node metastasis: a retrospective, single-center study

    • Katsuyuki Murai
    • Kohei Takizawa
    • Hiroyuki Ono

    Original Article 06 December 2018 Pages: 751 - 758

    

12. A novel TNM staging system for gastric cancer based on the metro-ticket paradigm: a comparative study with the AJCC-TNM staging system

    • Jun Lu
    • Zhi-Fang Zheng
    • Ping Li

    Original Article 05 January 2019 Pages: 759 - 768

    

13. Gastric sub-epithelial tumors: identification of gastrointestinal stromal tumors using CT with a practical scoring method

    • Ming Liu
    • Liheng Liu
    • Erhu Jin

    Original Article 09 December 2018 Pages: 769 - 777

    

14. Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancer

    • Toshifumi Yamaguchi
    • Satoru Iwasa
    • Narikazu Boku

    Original Article 02 January 2019 Pages: 778 - 784

    

15. Predictive value of MLH1 and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer

    • Tadayoshi Hashimoto
    • Yukinori Kurokawa
    • Yuichiro Doki

    Original Article 08 January 2019 Pages: 785 - 792

    

16. Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer

    • Akinori Sasaki
    • Yoshiaki Nakamura
    • Kohei Shitara

    Original Article 09 January 2019 Pages: 793 - 802

    

17. Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer

    • Manish A. Shah
    • Yoon-Koo Kang
    • Sanne Lysbet de Haas

    Original Article 31 January 2019 Pages: 803 - 816

    

18. Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial

    • Toshihiko Doi
    • Satoru Iwasa
    • Morihiro Watanabe

    Original Article Open access 04 December 2018 Pages: 817 - 827

    

19. Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study

    • Yung-Jue Bang
    • Yoon-Koo Kang
    • Hyun Cheol Chung

    Original Article Open access 25 March 2019 Pages: 828 - 837

    

20. Long-term outcomes and prognostic factors with non-curative endoscopic submucosal dissection for gastric cancer in elderly patients aged ≥ 75 years

    • Yosuke Toya
    • Masaki Endo
    • Takayuki Matsumoto

    Original Article 17 December 2018 Pages: 838 - 844

    

21. Surgical risk and benefits of laparoscopic surgery for elderly patients with gastric cancer: a multicenter prospective cohort study

    • Michitaka Honda
    • Hiraku Kumamaru
    • Naoki Hiki

    Original Article 11 December 2018 Pages: 845 - 852

    

22. Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset

    • Shogo Hayashi
    • Mitsuro Kanda
    • Yasuhiro Kodera

    Original Article 27 November 2018 Pages: 853 - 863

    

23. Impact of preoperative wait time on survival in patients with clinical stage II/III gastric cancer

    • Kenichiro Furukawa
    • Tomoyuki Irino
    • Masanori Terashima

    Original Article 10 December 2018 Pages: 864 - 872

    

24. Prospective feasibility study for single-tracer sentinel node mapping by ICG (indocyanine green) fluorescence and OSNA (one-step nucleic acid amplification) assay in laparoscopic gastric cancer surgery

    • Yoshiaki Shoji
    • Koshi Kumagai
    • Naoki Hiki

    Original Article 03 January 2019 Pages: 873 - 880

    

25. Pylorus-preserving gastrectomy for early cancer involving the upper third: can we go higher?

    • Chun-Chao Zhu
    • Hui Cao
    • Han-Kwang Yang

    Original Article 19 February 2019 Pages: 881 - 891

    

26. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer

    • Taro Funakoshi
    • Shin’ichi Miyamoto
    • Tsutomu Chiba

    Case Report 12 December 2018 Pages: 892 - 898

    

27. Clinical implications of CTNNA1 germline mutations in asymptomatic carriers

    • Patrick R. Benusiglio
    • Chrystelle Colas
    • Florence Coulet

    Short Communication 04 December 2018 Pages: 899 - 903

    

28. Outcomes of endoscopic submucosal dissection for gastric epithelial neoplasm in chronic kidney disease patients: propensity score-matched case–control analysis, methodological and statistical issues

    • Yahya Salimi
    • Ibrahim Abdollahpour

    Letter to the Editor 18 December 2018 Pages: 904 - 905

29. Correction to: Oncological safety of proximal gastrectomy for T2/T3 proximal gastric cancer

    • Masahiro Yura
    • Takaki Yoshikawa
    • Toshirou Nishida

    Correction 08 April 2019 Pages: 906 - 906

30. Nishi Memorial Award in Gastric Cancer

    Announcement 09 March 2019 Pages: 907 - 907